Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

MCO-010 receives Orphan and RMAT designations, highlighting its potential as a groundbreaking therapy for various retinal ...

Neurotech Pharmaceuticals enhances its leadership by appointing Peter J. McDonnell, MD, a leading ophthalmology expert, to its Board of Directors.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Technological advancements, including VR, AR, and AI, have revolutionized ophthalmology education, offering immersive simulations for skill enhancement and remote learning. The COVID-19 pandemic ...

In episode 1, Bill Trattler, MD, shares practical advice on documentation, patient communication, keratoconus management, and ...

Discover how dropless vitrectomy with suprachoroidal injection effectively controls inflammation, offering a promising ...

The goal is to provide an end-to-end operating system that unifies clinical, operational, and financial workflows.

Ahead of the September 8 meeting in Paris, the program co-chair of the event and current president of the American Academy of ...

Kriya is developing gene therapies targeting chronic diseases such as geographic atrophy, trigeminal neuralgia, and type 1 ...

FDA issues a complete response letter to Outlook Therapeutics for ONS-5010, citing insufficient evidence of effectiveness for ...

Studies have shown that fewer post-LASIK eyes end up within that coveted plus or minus 0.50 D of the intended target compared ...